Hyperkalemia is perceived as a barrier to implement guideline-directed medical therapy (GDMT) in patients with cardiorenal disease. In this educational program, a multidisciplinary faculty discusses strategies for managing hyperkalemia in HF patients with CKD while maintaining RAASi therapy.
This course consists of 3 episodes. Watch all episodes, answer pre- and post-test questions, and start earning CME credits.
This educational program consists of 3 presentations on the management of hyperkalemia in cardiorenal disease.
Challenges of managing hyperkalemia in HF patients with CKD while maintaining RAAS inhibitor therapy - Gianluigi Savarese, MD, PhD - Stockholm, Sweden
An multidisciplinary clinical dialogue: Optimizing long-term goals: practical approaches to novel potassium binder use in cardiorenal care - Aaron Wong, MD (Bridgend, UK) and James Burton, MD (Leicester, UK)
Summarizing multidisciplinary strategies: Where do we go from here? - Gianluigi Savarese, MD, PhD - Stockholm, Sweden
For questions regarding this activity, please contact us at info@pace-cme.org.
After participating in this educational activity, participants should be better able to:
This activity has been designed to meet the educational needs of cardiologist and nephrologists as well as all other physicians, physician assistants, nurse practitioners, nurses, pharmacists, and healthcare providers involved in managing patients with hyperkalemia.
This enduring activity is accredited by the European Board for Accreditation of Continuing Education for Health Professional (EBAC) for 39 minutes of effective education time.
Through an agreement between EBAC and the American Medical Association, physicians may convert EBAC External CME credits to AMA PRA Category 1 Credits™. Information on the process to convert EBAC credit to AMA credit can be found on the AMA website. Other health care professionals may obtain from the AMA a certificate of having participated in an activity eligible for conversion of credit to AMA PRA Category 1 Credit™.
Today’s healthcare environment is constantly evolving and advances of medical science occur at an accelerating pace. CME/CE plays an important role in the clinical environment and is an essential element of physician training, learning, and improvement, thereby importantly contributing to optimal patient care. Since 2000, MEDCON’s mission is to deliver high quality within the world of medical education by creating forums like PACE-CME, organizing live meetings, and providing online education. We aim to stimulate the review, exchange, and assimilation of key scientific findings to improve patients’ health, to raise awareness of new science underlying various disease states, and to accelerate the translation of this information into clinical practice.
Funding for this educational program was provided by an unrestricted educational grant from AstraZeneca.
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of PACE-CME.
Release Date:
Expiration Date:
